Compare IX & WST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IX | WST |
|---|---|---|
| Founded | 1950 | 1923 |
| Country | Japan | United States |
| Employees | N/A | N/A |
| Industry | Diversified Financial Services | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 27.6B | 20.2B |
| IPO Year | 1970 | N/A |
| Metric | IX | WST |
|---|---|---|
| Price | $28.74 | $266.98 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 10 |
| Target Price | N/A | ★ $346.78 |
| AVG Volume (30 Days) | 141.0K | ★ 661.3K |
| Earning Date | 11-12-2025 | 10-23-2025 |
| Dividend Yield | ★ 2.63% | 0.33% |
| EPS Growth | ★ 11.37 | 0.17 |
| EPS | 2.62 | ★ 6.75 |
| Revenue | ★ $20,512,909,787.00 | $3,017,900,000.00 |
| Revenue This Year | $8.93 | $7.01 |
| Revenue Next Year | $3.27 | $6.20 |
| P/E Ratio | ★ $10.71 | $39.63 |
| Revenue Growth | ★ 6.22 | 4.92 |
| 52 Week Low | $17.75 | $187.43 |
| 52 Week High | $28.86 | $348.90 |
| Indicator | IX | WST |
|---|---|---|
| Relative Strength Index (RSI) | 77.38 | 45.27 |
| Support Level | $27.61 | $263.38 |
| Resistance Level | $28.20 | $274.56 |
| Average True Range (ATR) | 0.32 | 7.32 |
| MACD | 0.13 | -0.79 |
| Stochastic Oscillator | 98.61 | 15.52 |
ORIX Corp is a diversified financial services company with operations in Corporate Financial Services, Maintenance Leasing, Real Estate, PE Investment and Concession, Environment and Energy, Insurance, Banking and Credit, Aircraft and Ships, ORIX USA, ORIX Europe, Asia, and Australia and engages in various other fee businesses by providing products and services aligned with customer needs to its core customer base of domestic small and medium-sized enterprises. Orix's numerous divisions finance leases of large-ticket items like ships, airplanes, and technology equipment. The company generates the majority of its revenue from Corporate Financial Services and Maintenance Leasing operations and Real Estate operations.
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.